{
  "id": "purine",
  "title": "Purine",
  "lang": "en",
  "source_lang": "en",
  "summary": "Purine is a nitrogen-containing ring system whose derivatives form genetic material, transfer cellular energy, regulate signaling, and undergo specialized metabolic pathways.",
  "category": "science",
  "subcategory": "chemistry",
  "type": "concept",
  "aliases": [
    "9H-purine",
    "imidazo[4,5-d]pyrimidine"
  ],
  "generated_at": "2026-11-02",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/purine/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/purine/",
      "json": "https://aiwiki.page/zh/purine.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Purine is a nitrogen-containing heterocyclic compound with the molecular formula \\(\\mathrm{C_5H_4N_4}\\). Its structure consists of two fused rings: a six-membered pyrimidine ring and a five-membered imidazole ring. The term also denotes the extensive family of compounds derived from this ring system. Among these derivatives, adenine and guanine are especially important because they are constituents of DNA and RNA. The unsubstituted parent compound is primarily a chemical reference structure; most biological discussion concerns substituted purines and their sugar- and phosphate-containing derivatives.\n\nPurine compounds connect genetic information with the chemical and regulatory processes that sustain life. Purine nucleotides serve as building blocks of nucleic acids, carriers of activated chemical groups, components of cofactors, and signaling molecules. Adenosine triphosphate (ATP) occupies a central position in energy transfer, while guanosine triphosphate (GTP) helps control protein synthesis and molecular switches. Their synthesis, recycling, and degradation form an interconnected part of metabolism. In humans, the degradation product urate is also important in several well-characterized metabolic disorders."
    },
    {
      "heading": "Chemical structure, numbering, and molecular properties",
      "text": "Purine belongs to the heterocyclic aromatic compounds studied in organic chemistry. Its fused ring system contains nine ring atoms, four of which are nitrogen. The six-membered ring contains positions 1 through 6, with nitrogen at positions 1 and 3; the five-membered ring adds positions 7, 8, and 9, with nitrogen at 7 and 9. Positions 4 and 5 are shared by both rings. This numbering is essential for distinguishing substituents, identifying metabolic transformations, and describing the points at which purine bases attach to sugars.\n\nThe purine framework is approximately planar and has a delocalized aromatic system containing ten \\(\\pi\\) electrons. Different nitrogen atoms contribute differently to this electronic structure. A pyridine-like nitrogen possesses a lone pair that can participate in proton binding without providing the same pair to the aromatic system, whereas a pyrrole-like nitrogen contributes its lone pair to aromaticity. These distinctions help explain the distribution of basicity and reactivity across the ring. The molecular behavior of purine therefore cannot be understood simply by counting nitrogen atoms.\n\nPurine can exist in different tautomeric forms, which differ in the position of a hydrogen atom and the associated arrangement of bonds. The 9H and 7H forms are important examples. Their relative abundance depends on the molecular environment, including solvent and substitution. This behavior is a form of isomerism, but it differs from the existence of compounds with entirely different ring connectivity. Biological purines also display tautomerism, although the structures favored in ordinary cellular conditions are strongly constrained by their substituents and interactions with surrounding molecules.\n\nThe parent compound has a molar mass of approximately \\(120.11\\ \\mathrm{g\\,mol^{-1}}\\). Its protonation and deprotonation behavior differs substantially from that of many biologically important derivatives. Adding an amino group, a carbonyl group, or a methyl substituent changes electron distribution, hydrogen bonding, and solubility. Consequently, values measured for purine itself cannot simply be assigned to adenine, guanine, caffeine, or uric acid. The relevant chemical species must also be specified when discussing behavior at a particular pH.\n\nPurine rings participate in both specific and nonspecific molecular interactions. Ring nitrogens and attached functional groups can donate or accept hydrogen bonds, while their planar surfaces support stacking interactions with other aromatic groups. These properties are crucial in nucleic acids and in the binding sites of enzymes. They also explain why purine-like structures are common in drug discovery: relatively small changes to the ring can alter recognition by an enzyme or receptor without eliminating the overall shape of the scaffold."
    },
    {
      "heading": "Major derivatives and biochemical terminology",
      "text": "Adenine is 6-aminopurine: it carries an amino group at carbon 6. Guanine is 2-amino-6-oxopurine, with an amino group at carbon 2 and an oxygen-containing group at carbon 6. These substitutions establish different patterns of hydrogen-bond donors and acceptors. Two further derivatives, hypoxanthine and xanthine, are central intermediates in purine metabolism. Hypoxanthine is 6-oxopurine, whereas xanthine contains oxo groups at positions 2 and 6. Uric acid, the terminal product of human purine breakdown, contains oxygen substituents at positions 2, 6, and 8.\n\nDistinguishing a base from a nucleoside and a nucleotide prevents several common ambiguities. A purine base is the nitrogenous ring-containing component. A nucleoside consists of that base attached to a sugar, usually ribose or 2-deoxyribose. A nucleotide adds one or more phosphate groups. Adenine, adenosine, and adenosine monophosphate therefore designate three different substances rather than interchangeable forms of the same name. The corresponding guanine series is guanine, guanosine, and guanosine monophosphate.\n\nIn the usual biological purine nucleosides, the sugar is joined through its anomeric carbon to nitrogen 9 of the base by a \\(\\beta\\)-N-glycosidic bond. Adenosine contains ribose, whereas deoxyadenosine contains 2-deoxyribose. The distinction matters because RNA and DNA require different sugar-containing precursors even when their bases are identical. Hypoxanthine attached to ribose forms inosine, which occurs in metabolism and in certain RNA molecules. Xanthosine is the corresponding ribonucleoside of xanthine.\n\nAbbreviations indicate the base, sugar context, and number of phosphates. AMP, ADP, and ATP denote adenosine mono-, di-, and triphosphate; GMP, GDP, and GTP denote the analogous guanosine compounds. A prefix “d” identifies a deoxyribonucleotide, as in dATP or dGTP. These abbreviations ordinarily refer to pools containing several protonation states and metal-ion complexes rather than to one isolated neutral molecule. In cells, ATP and GTP frequently function in association with magnesium ions, which influence enzyme recognition and phosphate-transfer chemistry.\n\nPurine derivatives also include many compounds outside nucleic-acid metabolism. The methylxanthines include caffeine, theophylline, and theobromine. Caffeine is 1,3,7-trimethylxanthine, theophylline is 1,3-dimethylxanthine, and theobromine is 3,7-dimethylxanthine. Their different methylation patterns produce distinct pharmacological properties. Other purines serve specialized ecological or developmental functions, including adenine-derived cytokinins involved in plant growth. Thus, “purine” names a structural family, not a single physiological role or a uniform category of dietary effect."
    },
    {
      "heading": "Purines in nucleic acids and genetic fidelity",
      "text": "Adenine and guanine are two of the four principal bases of DNA and RNA. Their larger, fused-ring structures distinguish them from the single-ring pyrimidine bases: cytosine, thymine, and uracil. In canonical double-stranded DNA, adenine pairs with thymine and guanine pairs with cytosine. Pairing a purine with a pyrimidine maintains a relatively consistent distance between the two sugar-phosphate backbones. Purine–purine or pyrimidine–pyrimidine pairings generally require altered geometry and are not equivalent substitutes for standard Watson–Crick pairs.\n\nAn adenine–thymine pair normally contains two hydrogen bonds, whereas a guanine–cytosine pair contains three. These counts describe the pairing pattern but do not alone determine DNA stability. Stacking between neighboring bases, surrounding ions, hydration, sequence, and temperature also contribute. In the polymer, nucleotides are connected through phosphodiester bonds between sugars and phosphates; the bases project inward and provide sequence-specific recognition surfaces. Their aromatic stacking is a major component of the structure’s stability.\n\nRNA uses uracil rather than thymine as its principal adenine partner. Its structural repertoire also includes noncanonical pairs, especially guanine–uracil wobble pairs, which occur in folded RNA and in some codon–anticodon interactions. Inosine is another important purine-containing RNA constituent. It can arise through adenosine deamination and can recognize more than one base in suitable structural contexts. In certain transfer RNAs, inosine at the wobble position expands the set of codons that a single anticodon can recognize.\n\nPurine chemistry also creates vulnerabilities in genetic material. Hydrolytic loss of an adenine or guanine base produces an abasic site, a lesion that lacks the coding component of a nucleotide. Deamination changes adenine to hypoxanthine and guanine to xanthine, altering their pairing properties. Oxidative damage can produce 8-oxoguanine, which can pair with adenine during copying. If unrepaired, this lesion can generate a G:C-to-T:A transversion. Dedicated DNA repair systems remove damaged bases or correct the resulting mismatches.\n\nTransient rare tautomers and alternative protonation states can also modify the pairing surfaces of purines. Such states are relevant to the chemical basis of copying errors, although their effects depend on the polymerase environment and reaction conditions. DNA polymerases discriminate among incoming nucleotides through geometric fit, catalytic alignment, and, in many cases, proofreading. Genetic fidelity therefore emerges from the interaction between purine chemistry, nucleotide-pool balance, polymerase selectivity, and repair rather than from base pairing alone."
    },
    {
      "heading": "De novo biosynthesis of the purine ring",
      "text": "De novo purine synthesis constructs the ring from small metabolic precursors. Unlike pyrimidine synthesis, in which the ring is made before attachment to ribose phosphate, the principal purine pathway builds the ring step by step on a ribose-derived scaffold. The starting activated sugar is 5-phosphoribosyl 1-pyrophosphate (PRPP), produced from ribose 5-phosphate and ATP. Ribose 5-phosphate is supplied chiefly through the pentose phosphate pathway, which links nucleotide production to carbohydrate metabolism.\n\nThe first committed reaction replaces the pyrophosphate group of PRPP with an amino group derived from glutamine, producing 5-phosphoribosylamine. A sequence of additions, rearrangements, and ring closures then produces inosine monophosphate (IMP), whose base is hypoxanthine. The origins of the ring atoms have been established by isotope-tracing experiments:\n\n- N1 comes from aspartate.\n- C2 and C8 come from formyl groups carried by tetrahydrofolate.\n- N3 and N9 come from glutamine.\n- C4, C5, and N7 come from glycine.\n- C6 comes from inorganic carbon, supplied through carbon dioxide or bicarbonate chemistry.\n\nThese sources show why purine synthesis draws on several branches of intermediary metabolism. Glycine contributes an intact three-atom unit, while folate coenzymes supply one-carbon groups at two separate stages. Glutamine donates nitrogen in reactions catalyzed by amidotransferases. ATP-dependent steps activate otherwise unfavorable transformations, and carbon–nitrogen bond formation progressively assembles the fused ring. In the standard human pathway, ten enzymatic transformations convert PRPP to IMP, with several reactions performed by multifunctional proteins.\n\nIMP is the branch point for adenine and guanine nucleotide synthesis. In the AMP branch, aspartate is added to IMP in a GTP-dependent reaction, forming adenylosuccinate; fumarate is then released to yield AMP. In the GMP branch, IMP is oxidized to xanthosine monophosphate, followed by ATP-dependent incorporation of glutamine-derived nitrogen to form GMP. The use of GTP in AMP synthesis and ATP in GMP synthesis helps couple production of the two nucleotide families rather than allowing either branch to operate independently of the other.\n\nThe organization of the pathway differs among organisms. Humans combine the second, third, and fifth transformations in the trifunctional GART protein, while other steps are grouped in proteins such as PAICS and ATIC. Some microorganisms use alternative enzymes, including different routes for converting aminoimidazole ribonucleotide to its carboxylated derivative. Such variation matters when comparing biochemical pathways or identifying microbial drug targets.\n\nPurine synthesis mainly produces ribonucleotides. Deoxyribonucleotides are subsequently generated through ribonucleotide reductase, which reduces the sugar component of ribonucleoside diphosphates. Additional phosphorylation yields the triphosphates required for DNA replication. Consequently, DNA precursor supply depends not only on purine-ring assembly but also on reduction, phosphorylation, and regulatory mechanisms that balance all four deoxyribonucleotide pools."
    },
    {
      "heading": "Salvage pathways, metabolic control, and cellular organization",
      "text": "Purine salvage recovers bases and nucleosides released during nucleic-acid turnover or obtained from extracellular sources. It avoids the energetic cost of constructing the ring anew. In humans, adenine phosphoribosyltransferase converts adenine and PRPP into AMP and pyrophosphate. Hypoxanthine-guanine phosphoribosyltransferase, commonly abbreviated HGPRT or HPRT, performs the corresponding reactions for hypoxanthine and guanine, producing IMP and GMP. These reactions place an existing purine base directly onto an activated ribose-phosphate scaffold.\n\nNucleosides enter additional recycling routes. Adenosine kinase converts adenosine to AMP using ATP, while purine nucleoside phosphorylase catalyzes phosphorolysis of inosine and guanosine, yielding their bases and ribose 1-phosphate. The term phosphorolysis is important: inorganic phosphate participates in cleavage, unlike simple hydrolysis by water. Nucleoside transporters move purine nucleosides across cellular membranes, connecting extracellular availability with intracellular recycling and degradation.\n\nDe novo synthesis and salvage share regulatory inputs. PRPP availability influences both, while purine nucleotides inhibit early steps in de novo synthesis through feedback regulation. Glutamine-PRPP amidotransferase is a major control point, responding to purine nucleotide abundance. Branch-specific regulation further limits imbalance: AMP inhibits its own synthetic branch, and guanine nucleotides regulate the GMP branch. Control also occurs at PRPP synthesis, which responds to nucleotide and phosphate concentrations.\n\nThese relationships explain why a salvage defect can increase, rather than merely decrease, purine production. Reduced consumption of PRPP makes more substrate available for de novo synthesis, while diminished salvage-derived nucleotide production can reduce feedback inhibition. The resulting increase in synthesis may ultimately increase degradation products. Purine metabolism is therefore a network of competing and coupled routes, not a simple one-way sequence from food to waste.\n\nThe pathway also has a spatial dimension. Under some experimental conditions, human de novo purine-synthesis enzymes assemble into dynamic clusters called purinosomes. Their formation is influenced by cellular conditions, including purine availability, and they have been observed in association with other cellular structures. Such assemblies may coordinate pathway activity and metabolite handling. However, visible clustering alone does not establish direct transfer of every intermediate between adjacent enzymes; the extent and mechanisms of metabolic channeling remain active research questions.\n\nDifferent cells rely to different degrees on synthesis, salvage, and extracellular supply. Mature erythrocytes depend heavily on salvage to maintain their adenine nucleotide pool, whereas proliferating cells have substantial requirements for new nucleotides. Balanced supply is important beyond total abundance: an excess of one deoxyribonucleotide relative to others can impair replication fidelity. Regulation must therefore match the quantities and proportions of purine nucleotides to energy use, RNA production, DNA synthesis, and other cellular demands."
    },
    {
      "heading": "Degradation, urate, and differences among organisms",
      "text": "Purine degradation removes sugars and amino groups and progressively oxidizes the ring system. Adenine nucleotides can reach hypoxanthine by more than one route. AMP may be deaminated to IMP and then dephosphorylated to inosine, or it may first be dephosphorylated to adenosine, which adenosine deaminase converts to inosine. Purine nucleoside phosphorylase then releases hypoxanthine. Guanine nucleotides are degraded through guanosine and guanine, with guanine deaminase producing xanthine.\n\nXanthine oxidoreductase catalyzes the oxidation of hypoxanthine to xanthine and xanthine to uric acid. The enzyme contains a molybdenum cofactor, iron–sulfur centers, and flavin adenine dinucleotide. It can function in forms that differ in their preferred electron acceptor: the dehydrogenase form primarily uses NAD\\(^+\\), whereas the oxidase form uses molecular oxygen. Under oxidase conditions, the reactions can generate reactive oxygen species. The balance between enzyme forms and electron acceptors is relevant to its physiological and pathological effects.\n\nAt normal human blood pH, uric acid exists predominantly as the singly charged urate ion. Its first acid dissociation constant corresponds to a \\(pK_a\\) of approximately 5.4, so “uric acid” in physiological discussions often refers collectively to the acid and its salts. Human plasma can become supersaturated with respect to monosodium urate at concentrations around \\(6.8\\ \\mathrm{mg\\,dL^{-1}}\\) under physiological conditions, although crystallization also depends on temperature, local chemistry, and nucleation. This is a physicochemical reference value, not a universal boundary at which crystals immediately form.\n\nHumans and other great apes lack functional urate oxidase, usually called uricase. Many other mammals possess this enzyme and can continue purine degradation toward the more soluble product allantoin. Other organisms use additional reactions that yield allantoate, urea, or ammonia. In many birds and reptiles, urate is a major route of nitrogen excretion, reflecting broader adaptations in nitrogen metabolism and water conservation. Purine breakdown therefore intersects with different physiological strategies across animal groups.\n\nIn humans, urate is eliminated through both the kidneys and the intestine. Kidney handling involves filtration, reabsorption, and secretion rather than passive filtration alone. Transport proteins, including URAT1, GLUT9, and ABCG2, contribute to urate homeostasis, with ABCG2 also important in intestinal export. Variation in transport activity helps explain why elevated blood urate can arise from reduced excretion as well as increased production.\n\nDiet supplies purines through nucleic acids and other cellular compounds, but endogenous turnover is also a major source. The effect of a food or metabolic condition cannot therefore be inferred solely from its total purine content. Production, salvage, degradation, tissue turnover, and excretion all influence the final urate concentration."
    },
    {
      "heading": "Energy transfer, cofactors, and signaling",
      "text": "ATP is the best-known purine nucleotide because it couples energy-releasing processes to energy-requiring reactions. The free-energy change of ATP hydrolysis depends on concentrations, magnesium binding, pH, and other conditions:\n\n\\[\\Delta G=\\Delta G^{\\circ\\prime}+RT\\ln Q.\\]\n\nHere, \\(Q\\) represents the appropriate reaction quotient. ATP is not an energy source because breaking a particular bond releases energy in isolation; bond breaking requires energy. The favorable overall reaction results from the relative free energies of reactants and products, including their hydration, charge distribution, and concentrations. ATP-dependent enzymes exploit this difference through coupled reaction mechanisms.\n\nGTP has similarly important but more specialized roles. During protein synthesis, GTP hydrolysis contributes to initiation, delivery of aminoacyl-tRNA, and translocation. In GTP-binding regulatory proteins, exchange of GDP for GTP and subsequent GTP hydrolysis switch interactions with other proteins. This principle operates in heterotrimeric G proteins and small GTPases such as Ras. The purine nucleotide is therefore both a chemical substrate and a molecular indicator of regulatory state.\n\nAdenine nucleotides also form parts of larger cofactors. NAD and NADP contain an adenosine moiety, although their principal redox chemistry occurs in the nicotinamide portion. Flavin adenine dinucleotide contains an adenine nucleotide linked to a flavin-containing unit, with the flavin carrying out its characteristic electron-transfer chemistry. Coenzyme A likewise contains an adenosine-derived component but transfers acyl groups through its terminal thiol. These examples distinguish structural recognition elements from the groups that directly perform a cofactor’s principal chemistry.\n\nCyclic nucleotides act as intracellular messengers. Cyclic AMP is produced from ATP by adenylyl cyclases, while cyclic GMP is generated from GTP by guanylyl cyclases. Their 3′,5′-cyclic phosphate linkage differs from the arrangements in ordinary nucleotide monophosphates. They regulate protein kinases, ion channels, and other effectors, and phosphodiesterases terminate their signals by opening the cyclic phosphate. These pathways connect receptor activation to changes in enzyme activity, cellular excitability, and gene regulation.\n\nExtracellular purines participate in purinergic signaling. Adenosine activates P1 receptors, which are G protein-coupled receptors. ATP and related nucleotides activate P2 receptors, comprising ATP-gated P2X ion channels and metabotropic P2Y receptors. Extracellular enzymes can convert ATP and ADP to AMP and then adenosine, changing the identity and duration of the signal. Thus, nucleotide breakdown outside a cell can generate a new signal rather than merely terminate an old one. Purinergic mechanisms contribute to neurotransmission, platelet responses, vascular regulation, and immune-cell activity."
    },
    {
      "heading": "Inherited disorders and pharmacological targets",
      "text": "Disorders of purine metabolism demonstrate the consequences of disrupting individual steps in a tightly connected network. Severe deficiency of HGPRT causes Lesch–Nyhan syndrome, an X-linked condition associated with urate overproduction, movement abnormalities, and characteristic behavioral manifestations. Partial HGPRT deficiency can produce less severe clinical patterns. The urate excess is explained by impaired salvage and increased de novo synthesis; the neurological manifestations are not explained simply by elevated urate and involve more complex effects of the enzyme deficiency.\n\nAdenosine deaminase deficiency is an established cause of severe combined immunodeficiency. Impaired metabolism of adenosine and deoxyadenosine allows toxic metabolites to accumulate. Increased deoxyadenosine nucleotides, including dATP, disrupt nucleotide metabolism and lymphocyte development. Purine nucleoside phosphorylase deficiency also causes immunodeficiency, often with pronounced T-cell involvement, through a different pattern of metabolite accumulation. These diseases show that purine degradation is necessary for cellular protection as well as disposal of excess material.\n\nOther inherited defects affect distinct parts of the pathway. Adenine phosphoribosyltransferase deficiency can produce poorly soluble 2,8-dihydroxyadenine, leading to urinary stones and kidney injury. Xanthine oxidoreductase deficiency can cause hereditary xanthinuria, characterized by low urate and increased xanthine. PRPP synthetase superactivity can increase purine production, while adenylosuccinate lyase deficiency interferes with reactions in purine synthesis and nucleotide interconversion. Their differing biochemical signatures allow disorders with superficially similar presentations to be distinguished.\n\nGout results from deposition of monosodium urate crystals and the inflammatory response to those crystals. Elevated serum urate is a major prerequisite, but not everyone with hyperuricemia develops gout. Uric-acid urinary stones are a related but chemically distinct problem in which urine pH is especially important. Xanthine oxidoreductase is a pharmacological target in urate-lowering therapy: allopurinol, through its active metabolite oxypurinol, and febuxostat reduce urate production by inhibiting this enzyme. Their mechanisms concern purine catabolism rather than removal of dietary purines from the body.\n\nPurine pathways are also targets in cancer treatment and immunosuppression. Mercaptopurine and thioguanine are purine analogues that undergo intracellular conversion to nucleotide metabolites. Their actions include interference with nucleotide metabolism and incorporation of thioguanine-containing products into nucleic acids. Azathioprine is converted to mercaptopurine-related metabolites. Genetic variation affecting enzymes such as TPMT and NUDT15 influences thiopurine metabolism and toxicity. Other agents inhibit IMP dehydrogenase or folate-dependent synthesis, limiting guanine nucleotide production or de novo purine synthesis.\n\nPharmacological specificity depends on more than resemblance to a natural base. Transport, activating enzymes, competing substrates, degradation, and tissue demand all influence biological effects. A compound that strongly inhibits a purified enzyme may behave differently in intact cells if it is not transported or converted to the relevant active form."
    },
    {
      "heading": "Historical development, synthesis, and analytical study",
      "text": "Purine chemistry developed from investigations of naturally occurring nitrogenous substances, including uric acid, caffeine, and constituents of nucleic acids. Uric acid had been isolated in the eighteenth century, before the structural relationships among these compounds were understood. In the late nineteenth century, Emil Fischer established much of the chemical framework connecting members of the purine family. He introduced the name purine in 1884 and reported synthesis of the parent compound in 1898. His work helped transform a collection of natural substances into a coherent structural class.\n\nSynthetic chemistry provided evidence for ring connectivity and substitution patterns before modern instrumental methods were available. A classic route associated with Wilhelm Traube constructs purines from appropriately substituted aminopyrimidines. Functionalization of an amino group followed by ring closure creates the fused imidazole portion. The route is adaptable because the starting pyrimidine’s substituents and the ring-closing reagent influence the final purine substitution pattern. Later methods broadened access to substituted bases, nucleosides, and non-natural analogues.\n\nPreparing purine nucleosides presents an additional problem: the desired sugar must attach at the correct nitrogen with the correct stereochemistry. Competing attachment at N7 rather than N9, or formation of an unwanted anomer, can produce compounds with very different biological properties. Protecting groups and controlled glycosylation reactions help direct synthesis. Enzymatic and chemoenzymatic methods offer complementary routes, exploiting the selectivity of nucleoside phosphorylases, kinases, or engineered enzymes. These techniques support the production of research probes and pharmaceutical intermediates.\n\nTwentieth-century isotope experiments revealed where the atoms of newly synthesized purines originate. Labeled glycine, formate, carbon dioxide, and nitrogen-containing precursors could be followed into specific ring positions. Work by John Buchanan and other investigators helped establish the sequence of de novo biosynthesis and the role of one-carbon metabolism. This approach connected structural chemistry to biochemical mechanism: knowing the final molecular formula was insufficient without identifying how cells assembled it.\n\nModern analysis commonly combines chromatography with ultraviolet detection or mass spectrometry to separate and quantify bases, nucleosides, and nucleotides. Purine bases absorb ultraviolet light, contributing to the approximately 260-nanometer absorption used in nucleic-acid analysis. Nuclear magnetic resonance and X-ray crystallography establish structures, conformations, and binding interactions. Stable-isotope tracing distinguishes newly synthesized molecules from recycled material and measures the movement of carbon or nitrogen through the pathway.\n\nPurine measurements require careful sample handling because metabolism can continue after collection. ATP may be converted to ADP, AMP, and downstream products, while extracellular release or cell breakage can alter apparent concentrations. Rapid quenching, suitable extraction, internal standards, and explicit separation of closely related metabolites are therefore integral to interpreting purine profiles. In pathway research, a metabolite’s concentration and its rate of production are separate quantities: isotope tracing can reveal high turnover even when the measured pool remains nearly constant."
    }
  ],
  "links": [
    "adenine",
    "dna",
    "rna",
    "nucleotide",
    "adenosine-triphosphate",
    "metabolism",
    "organic-chemistry",
    "isomerism",
    "molar-mass",
    "ph",
    "hydrogen-bond",
    "enzyme",
    "ribose",
    "pyrimidine",
    "phosphodiester-bond",
    "transfer-rna",
    "dna-repair",
    "dna-polymerase",
    "folate",
    "dna-replication",
    "hydrolysis",
    "feedback",
    "erythrocyte",
    "translation-biology",
    "cyclic-amp",
    "severe-combined-immunodeficiency",
    "gout",
    "cancer",
    "chromatography",
    "mass-spectrometry",
    "nuclear-magnetic-resonance",
    "x-ray-crystallography"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}